-
1
-
-
0018403326
-
Plasmid-mediated, transferable resistance to clindamycin and erythromycin in Bacteroides fragilis
-
Tally FP, Snydman DR, Gorbach SL, Malamy MH. Plasmid-mediated, transferable resistance to clindamycin and erythromycin in Bacteroides fragilis. J Infect Dis 1979;139:83-88
-
(1979)
J Infect Dis
, vol.139
, pp. 83-88
-
-
Tally, F.P.1
Snydman, D.R.2
Gorbach, S.L.3
Malamy, M.H.4
-
2
-
-
0019974721
-
Factors affecting the choice of antimicrobial therapy for anaerobic infection
-
Cuchural G, Tally FP. Factors affecting the choice of antimicrobial therapy for anaerobic infection. J Antimicrob Chemother 1982; 10(Suppl A):11-22.
-
(1982)
J Antimicrob Chemother
, vol.10
, Issue.SUPPL. A
, pp. 11-22
-
-
Cuchural, G.1
Tally, F.P.2
-
3
-
-
0027196388
-
Wound and intraabdominal infections: Microbiological considerations and approaches to treatment
-
Nichols RL, Smith JW. Wound and intraabdominal infections: microbiological considerations and approaches to treatment. Clin Infect Dis 1993;16(Suppl 4):S266-72.
-
(1993)
Clin Infect Dis
, vol.16
, Issue.SUPPL. 4
-
-
Nichols, R.L.1
Smith, J.W.2
-
4
-
-
0027174381
-
Clinical relevance of susceptibility testing of anaerobic bacteria
-
Rosenblatt JE, Brook I. Clinical relevance of susceptibility testing of anaerobic bacteria. Clin Infect Dis 1993;16(Suppl 4):S446-8.
-
(1993)
Clin Infect Dis
, vol.16
, Issue.SUPPL. 4
-
-
Rosenblatt, J.E.1
Brook, I.2
-
5
-
-
0034465384
-
Antimicrobial resistance and clinical outcome of Bacteroides bacteremia: Findings of a multicenter prospective observational trial
-
Nguyen MH, Yu VL, Morris AJ, et al. Antimicrobial resistance and clinical outcome of Bacteroides bacteremia: findings of a multicenter prospective observational trial. Clin Infect Dis 2000;30:870-876
-
(2000)
Clin Infect Dis
, vol.30
, pp. 870-876
-
-
Nguyen, M.H.1
Yu, V.L.2
Morris, A.J.3
-
6
-
-
0023943988
-
Susceptibility of the Bacteroides fragilis group in the United States: Analysis by site of isolation
-
Cuchural GJ Jr, Tally FP, Jacobus NV, et al. Susceptibility of the Bacteroides fragilis group in the United States: analysis by site of isolation. Antimicrob Agents Chemother 1988;32:717-722
-
(1988)
Antimicrob Agents Chemother
, vol.32
, pp. 717-722
-
-
Cuchural Jr., C.G.1
Tally, F.P.2
Jacobus, N.V.3
-
7
-
-
0019139839
-
Susceptibility of anaerobic bacteria to cefoperazone and other beta-lactam antibiotics
-
JacobusNV,TallyFP,BarzaM,GorbachSL.Susceptibilityofanaerobicbacteria- cefoperazoneandotherbeta-lactamantibiotics.ClinTher1980;3:34- 38(Pubitemid11236211)
-
(1980)
Clinical Therapeutics
, vol.3
, Issue.SPEC. ISS
, pp. 34-38
-
-
Jacobus, N.V.1
Tally, F.P.2
Barza, M.3
Gorbach, S.L.4
-
8
-
-
0003634052
-
-
National Committee for Clinical Laboratory Standards (NCCLS). approved standard, 4th ed. NCCLS document Villanova, PA: NCCLS
-
National Committee for Clinical Laboratory Standards (NCCLS). Methods for antimicrobial susceptibility testing of anaerobic bacteria: approved standard, 4th ed. NCCLS document M11-A4. Villanova, PA: NCCLS, 1997.
-
(1997)
Methods for Antimicrobial Susceptibility Testing of Anaerobic Bacteria
-
-
-
9
-
-
0019781230
-
A survey of Bacteroides susceptibility in the United States
-
Cuchural G, Jacobus N, Gorbach SL, Tally FP. A survey of Bacteroides susceptibility in the United States. J Antimicrob Chemother 1981; 8(Suppl D):27-31.
-
(1981)
J Antimicrob Chemother
, vol.8
, Issue.SUPPL. D
, pp. 27-31
-
-
Cuchural, G.1
Jacobus, N.2
Gorbach, S.L.3
Tally, F.P.4
-
10
-
-
0020672298
-
Susceptibility of the Bacteroides fragilis group in the United States in 1981
-
Tally FP, Cuchural GJ, Jacobus NV, et al. Susceptibility of the Bacteroides fragilis group in the United States in 1981. Antimicrob Agents Chemother 1983;23:536-540
-
(1983)
Antimicrob Agents Chemother
, vol.23
, pp. 536-540
-
-
Tally, F.P.1
Cuchural, G.J.2
Jacobus, N.V.3
-
11
-
-
34248336950
-
National survey on the susceptibility of Bacteroides fragilis group: Report and analysis of trends in the United States from 1997 to 2004
-
Snydman DR, Jacobus NV, McDermott LA, et al. National survey on the susceptibility of Bacteroides fragilis group: report and analysis of trends in the United States from 1997 to 2004. Antimicrob Agents Chemother 2007;51:1649-1655
-
(2007)
Antimicrob Agents Chemother
, vol.51
, pp. 1649-1655
-
-
Snydman, D.R.1
Jacobus, N.V.2
McDermott, L.A.3
-
12
-
-
0021180927
-
Antimicrobial susceptibilities of 1,292 isolates of the Bacteroides fragilis group in the United States: Comparison of 1981 with 1982
-
Cuchural GJ, Jr., Tally FP, Jacobus NV, et al. Antimicrobial susceptibilities of 1,292 isolates of the Bacteroides fragilis group in the United States: comparison of 1981 with 1982. Antimicrob Agents Chemother 1984;26:145-148
-
(1984)
Antimicrob Agents Chemother
, vol.26
, pp. 145-148
-
-
Cuchural Jr., G.J.1
Tally, F.P.2
Jacobus, N.V.3
-
13
-
-
0022413831
-
Nationwide study of the susceptibility of the Bacteroides fragilis group in the United States
-
Tally FP, Cuchural GJ, Jr., Jacobus NV, et al. Nationwide study of the susceptibility of the Bacteroides fragilis group in the United States. Antimicrob Agents Chemother 1985;28:675-677
-
(1985)
Antimicrob Agents Chemother
, vol.28
, pp. 675-677
-
-
Tally, F.P.1
Cuchural Jr., G.J.2
Jacobus, N.V.3
-
14
-
-
0025336018
-
The antimicrobial susceptibility patterns of the Bacteroides fragilis group in the United States, 1987
-
Cornick NA, Cuchural GJ, Jr., Snydman DR, et al. The antimicrobial susceptibility patterns of the Bacteroides fragilis group in the United States, 1987. J Antimicrob Chemother 1990;25:1011-1019
-
(1990)
J Antimicrob Chemother
, vol.25
, pp. 1011-1019
-
-
Cornick, N.A.1
Cuchural Jr., G.J.2
Snydman, D.R.3
-
15
-
-
0026549348
-
Antimicrobial susceptibility patterns of the Bacteroides fragilis group in the United States, 1989
-
Cuchural GJ Jr, Snydman DR, McDermott L, et al. Antimicrobial susceptibility patterns of the Bacteroides fragilis group in the United States, 1989. Clin Ther 1992;14:122-136
-
(1992)
Clin Ther
, vol.14
, pp. 122-136
-
-
Cuchural Jr., G.J.1
Snydman, D.R.2
McDermott, L.3
-
16
-
-
0028316139
-
National Anaerobic Susceptibility Study Group. Susceptibility variations in Bacteroides fragilis: A national survey
-
Snydman DR, Cuchural GJ; National Anaerobic Susceptibility Study Group. Susceptibility variations in Bacteroides fragilis: a national survey. Infect Dis Clin Pract 1994;3:S34-43.
-
(1994)
Infect Dis Clin Pract
, vol.3
-
-
Snydman, D.R.1
Cuchural, G.J.2
-
18
-
-
19244364519
-
Analysis of trends in antimicrobial resistance patterns among clinical isolates of Bacteroides fragilis group species from 1990 to 1994
-
Snydman DR, McDermott L, Cuchural GJ Jr, et al. Analysis of trends in antimicrobial resistance patterns among clinical isolates of Bacteroides fragilis group species from 1990 to 1994. Clin Infect Dis 1996; 23(Suppl 1):S54-65.
-
(1996)
Clin Infect Dis
, vol.23
, Issue.SUPPL. 1
-
-
Snydman, D.R.1
McDermott, L.2
Cuchural Jr., C.G.3
-
19
-
-
0032843496
-
Multicenter study of in vitro susceptibility of the Bacteroides fragilis group, 1995 to 1996, with comparison of resistance trends from 1990 to 1996
-
Snydman DR, Jacobus NV, McDermott LA, et al. Multicenter study of in vitro susceptibility of the Bacteroides fragilis group, 1995 to 1996, with comparison of resistance trends from 1990 to 1996. Antimicrob Agents Chemother 1999;43:2417-2422
-
Antimicrob Agents Chemother 1999
, vol.43
, pp. 2417-2422
-
-
Snydman, D.R.1
Jacobus, N.V.2
McDermott, L.A.3
-
20
-
-
0036059906
-
National survey on the susceptibility of Bacteroides fragilis group: Report and analysis of trends for 1997-2000
-
Snydman DR, Jacobus NV, McDermott LA, et al. National survey on the susceptibility of Bacteroides fragilis group: report and analysis of trends for 1997-2000. Clin Infect Dis 2002;35:S126-34.
-
(2002)
Clin Infect Dis
, vol.35
-
-
Snydman, D.R.1
Jacobus, N.V.2
McDermott, L.A.3
-
21
-
-
0043029870
-
Emergence of fluoroquinolone resistance among Bacteroides species
-
Golan Y, McDermott LA, Jacobus NV, et al. Emergence of fluoroquinolone resistance among Bacteroides species. J Antimicrob Chemother 2003;52:208-213
-
(2003)
J Antimicrob Chemother
, vol.52
, pp. 208-213
-
-
Golan, Y.1
McDermott, L.A.2
Jacobus, N.V.3
-
23
-
-
0034036414
-
Comparative in vitro activities of clinafloxacin and trovafloxacin against 1,000 isolates of Bacteroides fragilis group: Effect of the medium on test results
-
Snydman DR, Jacobus NV, McDermott LA, Supran SE. Comparative in vitro activities of clinafloxacin and trovafloxacin against 1,000 isolates of Bacteroides fragilis group: effect of the medium on test results. Antimicrob Agents Chemother 2000;44:1710-1712
-
(2000)
Antimicrob Agents Chemother
, vol.44
, pp. 1710-1712
-
-
Snydman, D.R.1
Jacobus, N.V.2
McDermott, L.A.3
Supran, S.E.4
-
24
-
-
0003495959
-
Wadsworth anaerobic bacteriology manual
-
5th ed. CA: Star Publishing
-
Summanen P, Baron EJ, Citron DM, Strong A, Wexler HM, Finegold SM. Wadsworth anaerobic bacteriology manual. 5th ed. Belmont, CA: Star Publishing, 1993.
-
(1993)
Belmont
-
-
Summanen, P.1
Baron, E.J.2
Citron, D.M.3
Strong, A.4
Wexler, H.M.5
Finegold, S.M.6
-
25
-
-
66249147009
-
Wadsworth-KTL anaerobic bacteriology manual
-
6th ed. CA: Star Publishing
-
Jousimies-Somer HR, Summanen P, Citron DM, Baron EJ, Wexler HM, Finegold SM. Wadsworth-KTL anaerobic bacteriology manual. 6th ed. Belmont, CA: Star Publishing, 2002.
-
(2002)
Belmont
-
-
Jousimies-Somer, H.R.1
Summanen, P.2
Citron, D.M.3
Baron, E.J.4
Wexler, H.M.5
Finegold, S.M.6
-
26
-
-
0003426615
-
Anaerobic laboratory manual
-
4th ed. VA: Virginia Polytechnic Institute and State University
-
Holdeman LV, Moore EC. Anaerobic laboratory manual. 4th ed. Blacksburg, VA: Virginia Polytechnic Institute and State University, 1977.
-
(1977)
Blacksburg
-
-
Holdeman, L.V.1
Moore, E.C.2
-
29
-
-
35048824537
-
-
Clinical and Laboratory Standards Institute (CLSI). approved standard. CLSI document Wayne, PA: CLSI
-
Clinical and Laboratory Standards Institute (CLSI). Methods for antimicrobial susceptibility testing of anaerobic bacteria: approved standard. CLSI document M11-A7. Wayne, PA: CLSI, 2007.
-
(2007)
Methods for Antimicrobial Susceptibility Testing of Anaerobic Bacteria
-
-
-
31
-
-
75749143744
-
-
Tygacil (tigecycline for injection) [package insert]. Philadelphia, PA: Wyeth Pharmaceuticals, 2007.
-
Tygacil (tigecycline for injection) [package insert]. Philadelphia, PA: Wyeth Pharmaceuticals, 2007.
-
-
-
|